Literature DB >> 22115070

Staphylococcal decolonisation: an effective strategy for prevention of infection?

Andrew E Simor1.   

Abstract

Staphylococcus aureus decolonisation--treatment to eradicate staphylococcal carriage--is often considered as a measure to prevent S aureus infection. The most common approach to decolonisation has been intranasal application of mupirocin either alone or in combination with antiseptic soaps or systemic antimicrobial agents. Some data support the use of decolonisation in surgical patients colonised with S aureus, particularly in those undergoing cardiothoracic procedures. Although this intervention has been associated with low rates of postoperative S aureus infection, whether overall rates of infection are also decreased is unclear. Patients undergoing chronic haemodialysis or peritoneal dialysis might benefit from decolonisation, although repeated courses of treatment are needed, and the effects are modest. Eradication of meticillin-resistant S aureus (MRSA) carriage has generally been difficult, and the role of decolonisation as an MRSA infection control measure is uncertain. The efficacy of decolonisation of patients with community-associated MRSA has not been established, and the routine use of decolonisation of non-surgical patients is not supported by data.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115070     DOI: 10.1016/S1473-3099(11)70281-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  29 in total

1.  Towards a Monoclonal Antibody-Based Therapy for Prevention and Treatment of Staphylococcus aureus Infections.

Authors:  Scott D Kobayashi; Frank R DeLeo
Journal:  J Infect Dis       Date:  2019-02-23       Impact factor: 5.226

2.  Mupirocin-induced mutations in ileS in various genetic backgrounds of methicillin-resistant Staphylococcus aureus.

Authors:  Andie S Lee; Yann Gizard; Joanna Empel; Eve-Julie Bonetti; Stephan Harbarth; Patrice François
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

Review 3.  Infection control in colon surgery.

Authors:  Donald E Fry
Journal:  Langenbecks Arch Surg       Date:  2016-06-27       Impact factor: 3.445

Review 4.  Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?

Authors:  Georgia R Sampedro; Juliane Bubeck Wardenburg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Reduction in methicillin-resistant Staphylococcus aureus colonisation: impact of a screening and decolonisation programme.

Authors:  Mark I Garvey; Jodie Winfield; Carolyn Wiley; Matthew Reid; Mike Cooper
Journal:  J Infect Prev       Date:  2016-08-04

6.  First outbreak of community-acquired MRSA USA300 in France: failure to suppress prolonged MRSA carriage despite decontamination procedures.

Authors:  O Baud; S Giron; C Aumeran; D Mouly; G Bardon; M Besson; J Delmas; B Coignard; A Tristan; F Vandenesch; G Illes; O Lesens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-11       Impact factor: 3.267

7.  Cost-effectiveness of pre-operative Staphylococcus aureus screening and decolonization.

Authors:  Susan E Kline; Erinn C Sanstead; James R Johnson; Shalini L Kulasingam
Journal:  Infect Control Hosp Epidemiol       Date:  2018-09-20       Impact factor: 3.254

8.  Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET.

Authors:  Laura R Marks; Emily A Clementi; Anders P Hakansson
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

9.  Persistent nasal methicillin-resistant staphylococcus aureus carriage in hemodialysis outpatients: a predictor of worse outcome.

Authors:  Holger Schmid; Andre Romanos; Helmut Schiffl; Stephan R Lederer
Journal:  BMC Nephrol       Date:  2013-04-23       Impact factor: 2.388

10.  Methicillin-resistant Staphylococcus aureus nasal carriage among patients receiving hemodialysis in Taiwan: prevalence rate, molecular characterization and de-colonization.

Authors:  Yu-Chuan Kang; Wei-Chen Tai; Chun-Chen Yu; Je-Ho Kang; Yhu-Chering Huang
Journal:  BMC Infect Dis       Date:  2012-11-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.